Taliban attacks Kabul and 3 more cities, all Indians safe

April 15, 2012

attack

Kabul, April 15: Heavily-armed Taliban suicide bombers today unleashed a wave of coordinated attacks in Afghanistan with several explosions and gunfire rocking the diplomatic area and Parliament in Kabul and three other cities but no Indian target was attacked.

According to India's ambassador to Afghanistan Gautam Mukhopadhyay, all Indians were safe.

ITBP director general Ranjit Sinha said there was no threat to the Indian embassy as it was located three to four km away from the scene of the attack this afternoon by the Taliban gunmen who came from different directions in perhaps an unprecedented assault of this nature.

Taliban claimed responsibility for around a dozen attacks by the gunmen in central Kabul which has stunned Afghan authorities. Any casualties is still unknown but Kabul police chief Mohammad Ayoubi Salangi was quoted as having said one attacker had been killed near the Parliament.

The militants attacked five-star Kabul Star Hotel in Wazir Akhbar Khan area of the capital and some tried to enter the Afghan parliament firing rockets but were engaged by security forces and driven back, officials said.

An unknown number of Taliban men armed with light and heavy weapons targeted Afghan governmental and International offices in three different areas of Kabul, police said.

A number of Taliban militants took positions at a newly-build building at the Shahr-e-Naw, a neighborhood of Kabul. They battled with Afghan forces for several hours after the militants began assaulting Western embassies.

The building is located close to American embassy, Turkey embassy, presidential palace, Iranian embassy, ISAF's headquarters, German embassy, UK embassy and different other diplomatic offices.

"I am on the spot and hearing the gunfire being traded between the suicide bombers and Afghan forces. Until now I heard several explosions," a PTI correspondent reported from the scene of attack.

In a text message to the reporters, Taliban spokesman Zabihullah Mujahed said: "Today, afternoon, at 1 pm, suicide bombings are happening by our Mujaheddeen at the ISAF headquarters, Parliament building, and other diplomatic offices in Kabul, and our enemies got many casualties."

The militants also struck at an airport in Jalalabad, Logar and Paktia.

A few others Taliban militants armed with heavy weapons positioned at a newly-build building are targeting Afghan parliament at the Darul Aman area of Kabul. The battle is ongoing between Afghan and Taliban militant forces, Afghan private tv, Tolo Tv, said today.

Another group of militants are targeting an ISAF's base, Turkish military base, and a training camp of Afghan national army at Pule Charkhi area of Kabul. They are targeting them from a building which they took under their control.

According to the eyewitness, suicide bombers had taken over the newly-built five-star hotel in Kabul, which was reportedly on fire.

Outside Kabul, two suicide bombers blew themselves up at the gates to Jalalabad airport in eastern city of Nangarhar province, wounding several people, police said.

Four bombers tried to enter the airport and two detonated their explosives when they were stopped at the gate, officials said. Two others were wounded and arrested.

Taliban militants also attacked ISAF's Provincial Reconstruction Team, Or PRT, in Jalalabad. "The battle is going on," Tolo tv said.

"In Jalalabad, several mujahidin attacked airport and PRT compound. The fighting is going on and our mujahidin are showing very strong resistance," the Taliban spokesman said.

According to reports, Taliban also attacked military academy compound in Jalalabad road, District No 9 of Kabul.

In Logar province, Taliban militants attacked a police compound, PRT compound and provincial intelligence department.

In Paktia province also, Taliban attacked police regional zone compound, airport, police headquarters and intelligence department. "The fighting is going on in all the provinces," Mujahed said.

"Our mujahidin are equipped with small and heavy weapons and also suicide vests," Mujahed said, adding "this attack was planned very well."

"Mujahidin attacked Afghanistan parliament compound and still the fighting is going on and we don't have casualties reports until now," the Taliban spokesman said.

The attackers also fired rockets at the parliament building and at the Russian embassy, officials said.

The embassies were not immediately available to comment.



Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
January 20,2020

Wuhan, Jan 20: A 45-year-old Indian woman has become the first foreigner in China to have contracted a mysterious virus, which is suspected to be Severe Acute Respiratory Syndrome (SARS)-like corona virus.

In 2002-2003, the SARS corona virus killed around 650 people in China and Hong Kong. This time, a new strain of virus with 62 cases have been reported in Wuhan and two in Shenzhen so far. 19 patients have been already cured and discharged, as per the Chinese media.

Official sources in Beijing said that the patient, Preeti Maheshwari, a school teacher at an international school, is undergoing treatment for the new strain of pneumonia outbreak, which has been spreading in two major cities of China - Wuhan and Shenzen. She has been on a ventilator in the intensive care unit.

Maheshwari was admitted to a local hospital after she seriously fell ill last Friday. Her husband, a businessman from Delhi, is allowed to visit her daily.

Following a second death due to the outbreak of the virus in Wuhan, India on Friday issued an advisory to its nationals travelling to China. Over 500 Indian medical students are studying in Wuhan.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 29,2020

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 2,2020

London/Milan, Jun 2: World Health Organization experts and a range of other scientists said on Monday there was no evidence to support an assertion by a high profile Italian doctor that the coronavirus causing the COVID-19 pandemic has been losing potency.

Professor Alberto Zangrillo, head of intensive care at Italy's San Raffaele Hospital in Lombardy, which bore the brunt of Italy's COVID-19 epidemic, on Sunday told state television that the new coronavirus "clinically no longer exists".

But WHO epidemiologist Maria Van Kerkhove, as well as several other experts on viruses and infectious diseases, said Zangrillo's comments were not supported by scientific evidence.

There is no data to show the new coronavirus is changing significantly, either in its form of transmission or in the severity of the disease it causes, they said.

"In terms of transmissibility, that has not changed, in terms of severity, that has not changed," Van Kerkhove told reporters.

It is not unusual for viruses to mutate and adapt as they spread, and the debate on Monday highlights how scientists are monitoring and tracking the new virus. The COVID-19 pandemic has so far killed more than 370,000 people and infected more than 6 million.

Martin Hibberd, a professor of emerging infectious disease at the London School of Hygiene & Tropical Medicine, said major studies looking at genetic changes in the SARS-CoV-2 virus that causes COVID-19 did not support the idea that it was becoming less potent, or weakening in any way.

"With data from more than 35,000 whole virus genomes, there is currently no evidence that there is any significant difference relating to severity," he said in an emailed comment.

Zangrillo, well known in Italy as the personal doctor of former Prime Minister Silvio Berlusconi, said his comments were backed up by a study conducted by a fellow scientist, Massimo Clementi, which Zangrillo said would be published next week.

Zangrillo told Reuters: "We have never said that the virus has changed, we said that the interaction between the virus and the host has definitely changed."

He said this could be due either to different characteristics of the virus, which he said they had not yet identified, or different characteristics in those infected.

The study by Clementi, who is director of the microbiology and virology laboratory of San Raffaele, compared virus samples from COVID-19 patients at the Milan-based hospital in March with samples from patients with the disease in May.

"The result was unambiguous: an extremely significant difference between the viral load of patients admitted in March compared to" those admitted last month, Zangrillo said.

Oscar MacLean, an expert at the University of Glasgow's Centre for Virus Research, said suggestions that the virus was weakening were "not supported by anything in the scientific literature and also seem fairly implausible on genetic grounds."

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.